05/12/2022 | Press release | Distributed by Public on 05/12/2022 05:48
Please select the service you want to use:
Smartlinks | Fennec Pharmaceuticals Inc. | News | Health | Biotechnology | Technology | Biotechnology | Science | Biotechnology | Research | Local News | Finance | Security Markets | Security Markets | Company News | Top Company News | Financial Services | Investment Services | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | Börse Frankfurt | Toronto Stock Exchange (TSX) | Börse Berlin | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Aequitas NEO Exchange | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | TSX Alpha Exchange | OmegaATS | Lynx ATS | Nasdaq CXC | Nasdaq CX2 | Canadian Securities Exchange (CSE) - Pure Trading | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact